Abstract: A method, a system, and a non-transitory computer-readable medium provides an interactive patient-level data visualization and analysis tool that illustrates a patient's health trajectory across multiple organ systems. Data from an electronic medical record system and one or more research databases are integrated into an analytics platform. A visualization tool plots the patient's health trajectory and overlays data from an entire user-defined disease cohort as a reference group to visualize a disease course of the patient compared to courses of other patients, with a same disease, selected by a user.

Abstract: In one aspect, lubricant compositions are described herein. In some embodiments, a lubricant composition described herein comprises a grease and milled metal sulfide particles dispersed in the grease. In other cases, a lubricant composition described herein comprises a grease, polytetrafluroethylene particles, zinc dithiophosphate, and molybdenum dialkyldithiocarbamate, wherein the polytetrafluroethylene particles, zinc dithiophosphate, and molybdenum dialkyldithiocarbamate are dispersed in the grease.

Abstract: In one aspect, lubricant compositions are described herein. In some embodiments, a lubricant composition described herein comprises a grease and milled metal sulfide particles dispersed in the grease. In other cases, a lubricant composition described herein comprises a grease, polytetrafluroethylene particles, zinc dithiophosphate, and molybdenum dialkylthiocarbamate, wherein the polytetrafluroethylene particles, zinc dithiophosphate, and molybdenum dialkyldithiocarbamate are dispersed in the grease.

Abstract: A multivalent anthelmintic vaccine targets both hookworm and schistosomiasis. The vaccine includes, at a minimum, a recombinant third-stage larval hookworm antigen, a recombinant adult stage hookworm antigen, and a recombinant schistosome antigen. Preferably, the hookworm antigens are Necator americanus antigens, although antigens from other hookworm species (e.g. Ancylostoma duodenale) may also be employed. The schistosome antigen is preferably a Schistosoma mansoni or a Schistosoma haematobium antigen although antigens from other schistosome species (e.g. Schistosoma japonicum) may also be employed. In some cases full or partial sequences of schistosome antigens may be fused with full or partial sequences of hookworm {Necator americanus) to produce recombinant chimeric antigens.

Abstract: A multivalent anthelmintic vaccine targets both hookworm and schistosomiasis. The vaccine includes, at a minimum, a recombinant third-stage larval hookworm antigen, a recombinant adult stage hookworm antigen, and a recombinant schistosome antigen. Preferably, the hookworm antigens are Necator americanus antigens, although antigens from other hookworm species (e.g. Ancylostoma duodenale) may also be employed. The schistosome antigen is preferably a Schistosoma mansoni or a Schistosoma haematobium antigen although antigens from other schistosome species (e.g. Schistosoma japonicum) may also be employed. In some cases full or partial sequences of schistosome antigens may be fused with full or partial sequences of hookworm {Necator americanus) to produce recombinant chimeric antigens.